发明授权
US07129268B2 Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
有权
过氧化物酶体增殖物激活受体活性亚芳基乙酸衍生物
- 专利标题： Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
- 专利标题（中）： 过氧化物酶体增殖物激活受体活性亚芳基乙酸衍生物
-
申请号： US10693161申请日： 2003-10-24
-
公开(公告)号： US07129268B2公开(公告)日： 2006-10-31
- 发明人: Lone Jeppesen , John Patrick Mogensen , Ingrid Pettersson , Per Sauerberg , Pavel Pihera , Miroslav Havranek
- 申请人： Lone Jeppesen , John Patrick Mogensen , Ingrid Pettersson , Per Sauerberg , Pavel Pihera , Miroslav Havranek
- 申请人地址： DK Bagsvaerd
- 专利权人： Novo Nordisk A/S
- 当前专利权人： Novo Nordisk A/S
- 当前专利权人地址： DK Bagsvaerd
- 代理商 Rosemarie R. Wilk-Orescan; Reza Green; Richard W. Bork
- 优先权： DK200201631 20021028; DK200300793 20030526
- 主分类号： A61K31/19
- IPC分类号： A61K31/19 ; C07C59/48 ; C07C69/76 ; C07D333/56 ; C07D307/38
摘要：
Novel compounds of the general formula (I), wherein Ar, R1, R2, X1, X2, Y1, Y, and Z are as defined in the specification, the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be useful in the treatment and/or prevention of conditions mediated by Peroxisome Proliferator-Activated Receptors (PPAR), in particular the PPARδ subtype.
公开/授权文献
- US20050070583A1 Novel compounds, their preparation and use 公开/授权日：2005-03-31
信息查询
